Correlation between Mesothelin and Chemotherapeutic Response in Patients of Epithelial Ovarian Carcinoma
碩士 === 臺灣大學 === 臨床醫學研究所 === 95 === Objective: Ovarian cancer is one of the leading cause of death among all gynecologic malignancies. The standard treatment of epithelial ovarian cancer (EOC) includes maximally debulking surgery followed by adjuvant chemotherapy. However, resistance to chemotherapy...
Main Authors: | Chia-Yen Huang, 黃家彥 |
---|---|
Other Authors: | 陳祈安 |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/47853504836679352057 |
Similar Items
-
Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis
by: KRISTIAN MADEIRA, et al.
Published: (2016-06-01) -
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
by: Yu Yi, et al.
Published: (2011-07-01) -
Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma
by: Jiayu Shen, et al.
Published: (2020-08-01) -
The Correlation of LIGHT and The Outcome of Epithelial Ovarian Carcinoma Patients
by: Yi-Yao Huang, et al.
Published: (2015) -
Serum Mesothelin in Epithelial Ovarian Cancer: a New Screening Marker and Prognostic Factor
by: Yu-Lin Tzeng, et al.
Published: (2006)